
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, experts say.

The COVID-19 antiviral ensitrelvir (Xocova), was recently approved by the Food and Drug Administration. The oral drug was approved as PEP, or post-exposure prophylaxis, meaning it is taken within 72 hours after coming in contact with someone who has COVID-19.

Artist Gillian Levine recently wrote and illustrated a comic sharing reasons to continue masking in 2026.

While most of the music industry has “moved on,” COVID-conscious performers have been working to prevent their shows from being superspreaders.

Despite a lack of COVID-19 precautions implemented by the 2026 Winter Olympics organizers in Italy, some athletes, teams, and their loved ones are protecting themselves from airborne pathogens by masking and isolating.Â

Illustrators who bravely explore the ongoing pandemic in their work break down stereotypes, contextualize differing experiences, build community, and raise awareness. These artists create spaces where audiences can reflect and engage with stories that can broaden our understanding of ourselves and the world.

To Olive and other Black queer community members, many Long COVID advocates pay lip service to the disease’s disproportionate effects on Black, Brown, and trans communities while excluding those voices from larger policy discussions.

During today’s United Nations (UN) event “Healthy Indoor Air: A Global Call to Action,” advocate Violet Affleck spoke about how clean air and masking are vital tools to address the ongoing COVID-19 pandemic.

A large study in Saudi Arabia found that 29% of participants who were infected with SARS-CoV-2 developed Long COVID. “This finding is consistent with the higher prevalence estimates reported globally and highlights the long-term burden of post-acute COVID-19 symptoms,” the authors of the study, published in BMC Infectious Diseases, wrote.

As someone with Long COVID, it’s demoralizing to see people in my circles party and engage in COVID-risky behaviors while I sit at home. It would be easy to turn my back on those people and give up on community organizations that minimize COVID-19. But that’s not me, and that’s not what being in community…
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance